Having shown that treatment of hepatoma cells with raloxifene and analog E led to reduced cell viability and induction of apoptosis, we next investigated the effects of analog E on human ER-negative/AhR-positive breast cancer cells, which we have previously shown to respond to raloxifene in an AhR-dependent manner. This evidence concerns the gene AHR and breast cancer.